Among adult patients with BRAF V600E mutated brain tumors, 15 of the 31 high-grade glioma patients had an objective response rate (ORR) of 33% with 3 Complete Responses (CR) and 12 PRs while the duration of response among all high-grade tumors was 13.6 months. Here, BRAF is linked to central nervous system cancer.